Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Avrobio Inc
(NQ:
AVRO
)
1.190
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Avrobio Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 12, 2023
Via
Benzinga
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 12, 2023
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
Via
Benzinga
Why Avrobio Shares Are Rising Wednesday
July 12, 2023
AVROBIO Inc (NASDAQ: AVRO) shares are trading higher Wednesday after the company said it will explore strategic alternatives.
Via
Benzinga
Avrobio Offloads Gene Therapy Program For Rare Genetic Disorder To Novartis
May 22, 2023
Via
Benzinga
Recap: Avrobio Q1 Earnings
May 11, 2023
Via
Benzinga
Avrobio Touts New Positive Data From Gaucher Disease Gene Therapy
December 07, 2022
Via
Benzinga
Recap: Avrobio Q2 Earnings
August 09, 2022
Avrobio (NASDAQ:AVRO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 07, 2023
Via
Benzinga
Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis
May 22, 2023
Shares of clinical-stage gene therapy company AVROBIO, Inc. (NASDAQ: AVRO) are trading higher Monday due to its agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program...
Via
Benzinga
Dow Tumbles 100 Points; Micron Technology Shares Plunge
May 22, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping over 100 points on Monday. The Dow traded down 0.36% to 33,306.30 while the NASDAQ rose 0.39% to 12,707.21. The S&P 500,...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 22, 2023
Via
Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 22, 2023
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.
Via
Benzinga
Nasdaq Rises Over 50 Points; Greenhill Shares Spike Higher
May 22, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded down 0.20% to 33,359.71 while the NASDAQ rose 0.47% to 12,717.37. The S&P...
Via
Benzinga
Why Is AVROBIO (AVRO) Stock Up 83% Today?
May 22, 2023
AVROBIO (AVRO) stock is seeing massive gains on Monday as the company sells one of its gene therapies to Novartis (NVS).
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 22, 2023
Via
Benzinga
Analyst Says Gene Therapy Data Update Offers Insights into Potential Pivotal Endpoints
May 18, 2023
Avrobio Inc (NASDAQ: AVRO) shares are trading higher after the company announced follow-up data demonstrating a durable treatment effect across key measures out to 36 months from a Phase 1/2 trial of...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 18, 2023
Via
Benzinga
Avrobio Touts Positive Data Gene Therapy Trial For Cystinosis, Showing Treatment Durability Of Up To 36 Months
May 18, 2023
Avrobio Inc (NASDAQ: AVRO) announced follow-up data demonstrating a durable treatment effect across key measures out to 36 months from a Phase 1/2 trial of an investigational gene therapy for...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 10, 2023
Via
Benzinga
AVROBIO Announces Clinical Data For Gaucher Disease Gene Therapy; Says 'Following positive feedback from FDA and MHRA, registrational, global Phase 2/3 clinical trial for GD3 planned for second half 2023'
December 07, 2022
New compelling clinical data from first-ever Gaucher disease type 3 (GD3) patient and four Gaucher disease type 1 (GD1) patients dosed with investigational AVR-RD-02 Data from first pediatric GD3...
Via
Benzinga
Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
November 29, 2022
Protalix BioTherapeutics, Inc. (NYSE AMERICAN: PLX), an Israeli biopharmaceutical company, and Chiesi Global Rare Diseases, a business unit of the Chiesi Group,
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 20, 2022
Via
Benzinga
Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions
September 20, 2022
As many investors are aware, options market data can provide some critical insight into future price movements of underlying common stock. It’s often possible to tell how the broader market perceives a...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
July 29, 2022
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 13, 2022
Via
Benzinga
AVROBIO Shares Climb As FDA Grants Orphan Drug Status To Genetic Disorder Candidate
July 13, 2022
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for AVROBIO’s (NASDAQ: AVRO) lead drug AVR-RD-05 for the treatment of mucopolysaccharidosis type II (MPSII), or Hunter...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 30, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.